NDC 0409-5010-01 - Marcaine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0409-5010
- Requested NDC
- 0409-5010-01
- Package NDCs from labels
- 0409-5010-01, 0409-5010-25
- Manufacturer
- Henry Schein, Inc.
- Effective date
- 2026-06-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Marcaine - Henry Schein, Inc. | Henry Schein, Inc. | 2026-06-24 | HUMAN PRESCRIPTION DRUG LABEL |
| Marcaine - Hospira, Inc. | Pfizer Healthcare India Private Limited | Hospira, Inc. | Pfizer Healthcare India Private Limited | 2026-05-29 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0409-5010-01 | Marcaine | 10 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 10 | 37 | |
| 0409-5010-25 | Marcaine | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 37 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0409-5010 | MARCAINE (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION MARCAINE WITH EPINEPHRINE (BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [HOSPIRA, INC.] | 33 | Current NDC, 2 package rows | 20250529_67578b56-7540-487e-1fba-481255620e78.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0409-5010-01 | ML - Milliliter | 0409-5010 | a316b0f7-5e83-4479-9acd-55c2962a5c86 | 1 | 2025-03-04 |
| 0409-5010-25 | ML - Milliliter | 0409-5010 | bb1b4573-3d2e-4637-be39-f65591e8acac | 1 | 2025-03-04 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Multi Flower | AESCULUS CARNEA, FLOS, AESCULUS HIPPOCASTANUM, FLOS, AGRIMONIA EUPATORIA, FLOS, BROMUS RAMOSUS, FLOS, CALLUNA VULGARIS, FLOS, CARPINUS BETULUS , FLOS, CASTANEA SATIVA, FLOS, CENTAURIUM UMBELLATUM, FLOS, CERATOSTIGMA WILLMOTTIANUM, FLOS, CICHORIUM INTYBUS, FLOS, CLEMATIS VITALBA, FLOS, CLEMATIS VITALBA, FLOS, FAGUS SYLVATICA, FLOS, GENTIANELLA AMARELLA, FLOS, HELIANTHEMUM NUMMULARIUM, FLOS, ILEX AQUIFOLIUM, FLOS, IMPATIENS GLANDULIFERA, FLOS, LARIX DECIDUA, FLOS, LONICERA CAPRIFOLIUM, FLOS | Energique, Inc. | 09c059e7-f748-402c-8447-af5b61169c58 | 2026-05-06 | Warnings | 059QF0KO0R |
| Folyra | MULTIVITAMIN | Oncora Pharma, LLC | cb182e26-17c5-4d00-869f-08823afeeee8 | 2026-04-28 | Warnings, Adverse reactions | PQ6CK8PD0R |
| Norvexa Mini | NORVEXA MINI | Florrax Pharmaceutical | 7c964ffd-4b14-43ef-9163-db21c6a1afc6 | 2026-04-27 | Warnings, Adverse reactions | PQ6CK8PD0R |
| Sodium Chloride | SODIUM CHLORIDE | Sportpharm LLC | a2c111f6-74d5-4a5d-82ac-d0f237488cb8 | 2026-04-24 | Warnings, Adverse reactions | 451W47IQ8X |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | Sportpharm LLC | 6f9ebeef-350a-495e-a0bf-c335ab48bf1c | 2026-04-24 | Boxed warning, Warnings, Adverse reactions | 1725078 7TQO7W3VT8 |
| Prenatal Plus Vitamins | PRENATAL WITH FERROUS FUMARATE AND FOLIC ACID | REMEDYREPACK INC. | 1b8ef3ea-5563-48ef-ba5e-27e0b454efb9 | 2026-04-23 | Boxed warning | PQ6CK8PD0R |
| Sodium Chloride | SODIUM CHLORIDE | Method Pharmaceuticals, LLC | 4b08859e-65bd-8255-e063-6394a90af614 | 2026-04-23 | Warnings | 451W47IQ8X |
| LIDOCAINE | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | Henry Schein Inc. | 1ca96c77-d983-496b-84a6-54709e80f532 | 2026-04-23 | Warnings, Adverse reactions | 30Q7KI53AK |
| Lidocaine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | Henry Schein Inc. | f8d90500-f797-4238-8dd2-b59cbcd89d12 | 2026-04-23 | Warnings, Adverse reactions | 30Q7KI53AK |
| Vitavera | VITAVERA | Oncora Pharma, LLC | 058b1921-21da-49d9-b9c1-3f5636087aea | 2026-04-21 | Warnings, Adverse reactions | PQ6CK8PD0R |
| Ringers | SODIUM CHLORIDE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE | ICU Medical, Inc. | a926f913-18fa-4a3e-bfd6-210e1e427960 | 2026-04-20 | Warnings, Adverse reactions | 451W47IQ8X |
| Cardioforce II | ABROTANUM, BOLDO, CIMICIFUGA RACEMOSA, KALI PHOSPHORICUM, TARAXACUM OFFICINALE, CONVALLARIA MAJALIS, MAGNESIA SULPHURICA, OLEANDER, NATRUM MURIATICUM, BELLIS PERENNIS | BioActive Nutritional, Inc. | 733bbb26-7698-4a1b-9dc8-7e3490ffc92b | 2026-04-17 | Warnings | 451W47IQ8X |
| Chromagen | FERROUS ASPARTO GLYCINATE, FERROUS FUMARATE, ASCORBIC ACID, FOLIC ACID, LEVOMEFOLATE GLUCOSAMINE, CYANOCOBALAMIN, ZINC, AND INTRINSIC FACTOR | Avion Pharmaceuticals, LLC | 13c5ed58-6333-498f-9ace-1049d7ae3552 | 2026-04-17 | Boxed warning, Adverse reactions | PQ6CK8PD0R |
| PRENATE DHA | ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL, DL-, FOLIC ACID, LEVOMEFOLATE CALCIUM, PYRIDOXINE HYDROCHLORIDE, CYANOCOBALAMIN, CALCIUM FORMATE, FERROUS ASPARTO GLYCINATE, MAGNESIUM OXIDE AND DOCONEXENT | Avion Pharmaceuticals, LLC | 8f2eca71-9a82-4a19-9206-36a04b865fe1 | 2026-04-17 | Boxed warning, Warnings, Adverse reactions | PQ6CK8PD0R |
| Thyroid HP | BARYTA CARBONICA, CALCAREA CARBONICA, FUCUS VESICULOSUS, IODIUM, NATRUM MURIATICUM, PULSATILLA, SPONGIA TOSTA, THYROIDINUM (SUIS) | BioActive Nutritional, Inc. | 3795820a-cf2a-4094-9a02-70e3757b7510 | 2026-04-17 | Warnings | 451W47IQ8X |
| DIANEAL Low Calcium with Dextrose | SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE | Vantive US Healthcare LLC | aa268d3f-7389-4f25-801f-5d4825495f08 | 2026-04-16 | Warnings, Adverse reactions | TU7HW0W0QT 451W47IQ8X |
| PEG 3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Wilshire Pharmaceuticals, Inc. | b251752d-7750-482a-9364-0acf4ad47cc8 | 2026-04-16 | Warnings, Adverse reactions | 451W47IQ8X |
| Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE | Fresenius Kabi USA, LLC | 99c6a1a9-cadf-435b-a332-ccc189afdfa9 | 2026-04-16 | Warnings, Adverse reactions | 451W47IQ8X |
| GoLYTELY | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Azurity Pharmaceuticals, Inc. | 7609ecf7-0ce0-4fbb-9c27-30987f689575 | 2026-04-15 | Warnings, Adverse reactions | 451W47IQ8X |
| TRILYTE | POLYETHYLENE GLYOCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE AND POTASSIUM CHLORIDE | Aurobindo Pharma Limited | 79f5e596-8d51-4227-afcc-f5e341150957 | 2026-04-15 | Warnings, Adverse reactions | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.